BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14570309)

  • 1. Effect of lipid excipients on in vitro pancreatic lipase activity.
    Subramanian R; Wasan KM
    Drug Dev Ind Pharm; 2003 Sep; 29(8):885-90. PubMed ID: 14570309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
    J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipolysis of the semi-solid self-emulsifying excipient Gelucire 44/14 by digestive lipases.
    Fernandez S; Rodier JD; Ritter N; Mahler B; Demarne F; Carrière F; Jannin V
    Biochim Biophys Acta; 2008 Aug; 1781(8):367-75. PubMed ID: 18571509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the inhibition of pancreatic and carboxylester lipases by protamine.
    Tsujita T; Matsuura Y; Okuda H
    J Lipid Res; 1996 Jul; 37(7):1481-7. PubMed ID: 8827520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triacylglycerols based on 2-(N-tert-butoxycarbonylamino)oleic acid are potent inhibitors of pancreatic lipase.
    Magrioti V; Verger R; Constantinou-Kokotou V
    J Med Chem; 2004 Jan; 47(2):288-91. PubMed ID: 14711301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chain length affects pancreatic lipase activity and the extent and pH-time profile of triglyceride lipolysis.
    Benito-Gallo P; Franceschetto A; Wong JC; Marlow M; Zann V; Scholes P; Gershkovich P
    Eur J Pharm Biopharm; 2015 Jun; 93():353-62. PubMed ID: 25936853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concerted action of human carboxyl ester lipase and pancreatic lipase during lipid digestion in vitro: importance of the physicochemical state of the substrate.
    Lindström MB; Sternby B; Borgström B
    Biochim Biophys Acta; 1988 Mar; 959(2):178-84. PubMed ID: 3349096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interest of multifunctional lipid excipients: case of Gelucire 44/14.
    Chambin O; Jannin V
    Drug Dev Ind Pharm; 2005 Jul; 31(6):527-34. PubMed ID: 16109625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digestion of triacylglycerols containing long-chain polyenoic fatty acids in vitro by colipase-dependent pancreatic lipase and human milk bile salt-stimulated lipase.
    Chen Q; Bläckberg L; Nilsson A; Sternby B; Hernell O
    Biochim Biophys Acta; 1994 Jan; 1210(2):239-43. PubMed ID: 8280776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of phosphatidylcholine and free fatty acids on the activity of pancreatic lipase-colipase.
    Larsson A; Erlanson-Albertsson C
    Biochim Biophys Acta; 1986 May; 876(3):543-50. PubMed ID: 3707983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro gastrointestinal lipolysis of four formulations of piroxicam and cinnarizine with the self emulsifying excipients Labrasol and Gelucire 44/14.
    Fernandez S; Chevrier S; Ritter N; Mahler B; Demarne F; Carrière F; Jannin V
    Pharm Res; 2009 Aug; 26(8):1901-10. PubMed ID: 19452130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of pancreatic lipase by poloxamer 407 may provide an adjunct treatment strategy for weight loss.
    Johnston TP; Goldberg IJ
    J Pharm Pharmacol; 2006 Aug; 58(8):1099-105. PubMed ID: 16872557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenytoin-lipid conjugates: chemical, plasma esterase-mediated, and pancreatic lipase-mediated hydrolysis in vitro.
    Scriba GK
    Pharm Res; 1993 Aug; 10(8):1181-6. PubMed ID: 8415405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sodium taurodeoxycholate, CaCl2 and albumin on the action of pancreatic lipase on droplets of trioleoylglycerol and the release of lipolytic products into aqueous media.
    Scow RO
    Biochimie; 1988 Sep; 70(9):1251-61. PubMed ID: 3147718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to rats.
    Ibrahim F; Gershkovich P; Sivak O; Wasan EK; Wasan KM
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1277-83. PubMed ID: 22989082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic lipase/colipase-mediated triacylglycerol hydrolysis is required for cholesterol transport from lipid emulsions to intestinal cells.
    Young SC; Hui DY
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):615-20. PubMed ID: 10215600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I hyperlipoproteinemia caused by lipoprotein lipase defect in lipid-interface recognition was relieved by administration of medium-chain triglyceride.
    Shirai K; Kobayashi J; Inadera H; Ohkubo Y; Mori S; Saito Y; Yoshida S
    Metabolism; 1992 Nov; 41(11):1161-4. PubMed ID: 1435285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human pancreatic lipase-colipase activity by mixed bile salt-phospholipid micelles.
    Patton JS; Carey MC
    Am J Physiol; 1981 Oct; 241(4):G328-36. PubMed ID: 7315970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydration of an amphiphilic excipient, Gelucire 44/14.
    Svensson A; Neves C; Cabane B
    Int J Pharm; 2004 Aug; 281(1-2):107-18. PubMed ID: 15288348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic lipase and pancreatic lipase-related protein 2, but not pancreatic lipase-related protein 1, hydrolyze retinyl palmitate in physiological conditions.
    Reboul E; Berton A; Moussa M; Kreuzer C; Crenon I; Borel P
    Biochim Biophys Acta; 2006 Jan; 1761(1):4-10. PubMed ID: 16497549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.